Dong-peng Hu

Suggest Changes
Learn More
PURPOSE To evaluate the effects of combining the assessment of circulating high-sensitivity C-reactive protein (hs-CRP) with that of Epstein-Barr virus DNA (EBV DNA) in the pretherapy prognostication(More)
  • 1